Terns Pharmaceuticals, Inc. · NASDAQ:TERN
Deep Track Capital, LP's stake in Terns Pharmaceuticals, Inc. fell to 2.97% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Deep Track Capital, LP's stake in Terns Pharmaceuticals, Inc. fell to 2.97%, 3,150,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 2.97%
- Shares
- 3,150,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 2.97% | 3,150,000 |
| Deep Track Biotechnology Master Fund, Ltd. | 2.97% | 3,150,000 |
| David Kroin | 2.97% | 3,150,000 |
Source
Related
- Terns Pharmaceuticals, Inc.
- Deep Track Capital, LP
- Terns Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2025
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2025
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Form 4 · Kuriakose Emil · May 5, 2026
- Form 4 · Gengos Andrew · May 5, 2026